Lu K - Search Results

1

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Wang J, Zhou C, Yao W, Wang Q, Min X, Chen G, Xu X, Li X, Xu F, Fang Y, Yang R, Yu G, Gong Y, Zhao J, Fan Y, Liu Q, Cao L, Yao Y, Liu Y, Li X, Wu J, He Z, Lu K, Jiang L, Hu C, Zhao W, Zhang B, Shi W, Zhang X, Cheng Y; CAPSTONE-1 Study Group. Wang J, et al. Among authors: lu k. Lancet Oncol. 2022 Jun;23(6):739-747. doi: 10.1016/S1470-2045(22)00224-8. Epub 2022 May 13. Lancet Oncol. 2022. PMID: 35576956 Clinical Trial.

2

Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.

Zhang M, Wang J, Shi W, Chen W, Li W, Shu Y, Liu P, Lu K. Zhang M, et al. Among authors: lu k. Chin Med J (Engl). 2014;127(10):1874-8. Chin Med J (Engl). 2014. PMID: 24824248

3

The in cis compound EGFR mutations in Chinese advanced non-small cell lung cancer patients.

Li M, Zhou CZ, Yang JJ, Lu S, Zheng D, Hu J, Zeng H, Lu Y, Lu KH, Li SA, Mao XR, Han-Zhang H, Lizaso A, Ye JY, Hu CP. Li M, et al. Cancer Biol Ther. 2019;20(8):1097-1104. doi: 10.1080/15384047.2019.1595280. Epub 2019 Apr 16. Cancer Biol Ther. 2019. PMID: 30990107 Free PMC article.

4

Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung Cancer.

Xiang Y, Zhang S, Fang X, Jiang Y, Fang T, Liu J, Lu K. Xiang Y, et al. Among authors: lu k. Curr Oncol. 2022 Oct 16;29(10):7816-7831. doi: 10.3390/curroncol29100618. Curr Oncol. 2022. PMID: 36290895 Free PMC article. Review.

5

Real world experience with camrelizumab in patients with advanced non-small cell lung cancer: a prospective multicenter cohort study (NOAH-LC-101).

Wang R, Shi M, Ji M, Han Z, Chen L, Liu Y, Lu K, Liu L, Chen B, Zhang X, Miao L, Shu Y. Wang R, et al. Among authors: lu k. Transl Lung Cancer Res. 2023 Apr 28;12(4):786-796. doi: 10.21037/tlcr-23-121. Epub 2023 Apr 25. Transl Lung Cancer Res. 2023. PMID: 37197631 Free PMC article.

6

Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations: A Narrative Review.

Jiang Y, Fang X, Xiang Y, Fang T, Liu J, Lu K. Jiang Y, et al. Among authors: lu k. Curr Oncol. 2023 May 28;30(6):5337-5349. doi: 10.3390/curroncol30060405. Curr Oncol. 2023. PMID: 37366888 Free PMC article. Review.

7

Almonertinib plus chemotherapy versus almonertinib alone in second-line treatment of advanced non-small cell lung cancer with mutated epidermal growth factor receptor: a retrospective study.

Fang X, Xiang Y, Lu K. Fang X, et al. Among authors: lu k. Front Oncol. 2023 Sep 11;13:1248690. doi: 10.3389/fonc.2023.1248690. eCollection 2023. Front Oncol. 2023. PMID: 37752994 Free PMC article.

8

Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study.

Li W, Xiong A, Yang N, Fan H, Yu Q, Zhao Y, Wang Y, Meng X, Wu J, Wang Z, Liu Y, Wang X, Qin X, Lu K, Zhuang W, Ren Y, Zhang X, Yan B, Lovly CM, Zhou C. Li W, et al. Among authors: lu k. J Clin Oncol. 2024 Aug 1;42(22):2660-2670. doi: 10.1200/JCO.24.00731. Epub 2024 Jun 1. J Clin Oncol. 2024. PMID: 38822758 Free PMC article. Clinical Trial.

9

Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study.

Yu Y, Guo Q, Zhang Y, Fang J, Zhong D, Liu B, Pan P, Lv D, Wu L, Zhao Y, Li J, Liu Z, Liu C, Su H, Fan Y, Zhang T, Liu A, Jin B, Wang Y, Zhou J, Zhang Z, Ran F, Song X, Shi M, Su W, Lu S; study group. Yu Y, et al. Lancet Respir Med. 2024 Sep 10:S2213-2600(24)00211-X. doi: 10.1016/S2213-2600(24)00211-X. Online ahead of print. Lancet Respir Med. 2024. PMID: 39270695

10

Long non-coding RNA MVIH indicates a poor prognosis for non-small cell lung cancer and promotes cell proliferation and invasion.

Nie FQ, Zhu Q, Xu TP, Zou YF, Xie M, Sun M, Xia R, Lu KH. Nie FQ, et al. Tumour Biol. 2014 Aug;35(8):7587-94. doi: 10.1007/s13277-014-2009-7. Epub 2014 May 4. Tumour Biol. 2014. PMID: 24793017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,986 results

Search Page

Filters